About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Change of Registered Office and Principal Place of Business

January 20, 2017

Click here to read more

Post navigation

Phosphagenics Newsletter – December 2016

Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan

Related Posts

Phosphagenics Investor Presentation

September 1, 2017

Phosphagenics Full Year Financial Results

February 28, 2017

Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial

January 29, 2016

Recent Posts

Biotech Webinar
September 23, 2021
Enrolment commences for Phase I human clinical trial
September 15, 2021
Horizon 3 Biotech | Dr Paul Gavin
September 6, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.